Optimal Timing of Mesenchymal Stem Cell Therapy for Neonatal Intraventricular Hemorrhage
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park W.S.[Park W.S.] | - |
dc.contributor.author | Sung S.I.[Sung S.I.] | - |
dc.contributor.author | Ahn S.Y.[Ahn S.Y.] | - |
dc.contributor.author | Sung D.K.[Sung D.K.] | - |
dc.contributor.author | Im G.H.[Im G.H.] | - |
dc.contributor.author | Yoo H.S.[Yoo H.S.] | - |
dc.contributor.author | Choi S.J.[Choi S.J.] | - |
dc.contributor.author | Chang Y.S.[Chang Y.S.] | - |
dc.date.accessioned | 2021-08-01T21:25:49Z | - |
dc.date.available | 2021-08-01T21:25:49Z | - |
dc.date.created | 2016-08-07 | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 0963-6897 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/41835 | - |
dc.description.abstract | We recently showed that intraventricular transplantation of human umbilical cord blood (UCB)-derived mesenchymal stem cells (MSCs) significantly attenuated posthemorrhagic hydrocephalus (PHH) and brain injury after severe intraventricular hemorrhage (IVH) in newborn rat pups. The purpose of this study was to optimize the timing of MSC transplantation for severe IVH. Severe IVH was induced by injecting 100 mu l of blood into each ventricle of Sprague-Dawley rats on postnatal day 4 (P4). Human UCB-derived MSCs (1 x 10(5) cells in 10 mu l of normal saline) were transplanted intraventricularly under. stereotaxic guidance either early at P6 or late at P11. Serial brain MRIs and behavioral function tests, such as negative geotaxis and rotarod tests, were performed. At P32, brain tissue samples were obtained for histological and biochemical analyses. Intracerebroventricular transplantation of MSCs significantly attenuated the development of PHH, behavioral impairment, increased apoptosis and astrogliosis, reduced corpus callosum thickness and brain myelination, and upregulated inflammatory cytokines including interleukin (IL)-1 alpha, IL-1 beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha) at P6 but not at P11 after induction of severe IVH. Intracerebroventricular transplantation of human UCB -derived MSCs attenuated PHH and brain injury after severe IVH in newborn rats in a time-dependent manner. Significant neuroprotection was only demonstrated when administered early at 2 days after induction but not late at 7 days after induction of severe IVH. | - |
dc.publisher | COGNIZANT COMMUNICATION CORP | - |
dc.subject | UMBILICAL-CORD BLOOD | - |
dc.subject | VERSUS-HOST-DISEASE | - |
dc.subject | INDUCED LUNG INJURY | - |
dc.subject | INTRATRACHEAL TRANSPLANTATION | - |
dc.subject | VENTRICULAR DILATATION | - |
dc.subject | CEREBRAL-ISCHEMIA | - |
dc.subject | CONTROLLED-TRIAL | - |
dc.subject | ADIPOSE-TISSUE | - |
dc.subject | BONE-MARROW | - |
dc.subject | RAT | - |
dc.title | Optimal Timing of Mesenchymal Stem Cell Therapy for Neonatal Intraventricular Hemorrhage | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Park W.S.[Park W.S.] | - |
dc.contributor.affiliatedAuthor | Chang Y.S.[Chang Y.S.] | - |
dc.identifier.doi | 10.3727/096368915X689640 | - |
dc.identifier.scopusid | 2-s2.0-84973102841 | - |
dc.identifier.wosid | 000377847700010 | - |
dc.identifier.bibliographicCitation | CELL TRANSPLANTATION, v.25, no.6, pp.1131 - 1144 | - |
dc.relation.isPartOf | CELL TRANSPLANTATION | - |
dc.citation.title | CELL TRANSPLANTATION | - |
dc.citation.volume | 25 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 1131 | - |
dc.citation.endPage | 1144 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalResearchArea | Research & Experimental Medicine | - |
dc.relation.journalResearchArea | Transplantation | - |
dc.relation.journalWebOfScienceCategory | Cell & Tissue Engineering | - |
dc.relation.journalWebOfScienceCategory | Medicine, Research & Experimental | - |
dc.relation.journalWebOfScienceCategory | Transplantation | - |
dc.subject.keywordPlus | UMBILICAL-CORD BLOOD | - |
dc.subject.keywordPlus | VERSUS-HOST-DISEASE | - |
dc.subject.keywordPlus | INDUCED LUNG INJURY | - |
dc.subject.keywordPlus | INTRATRACHEAL TRANSPLANTATION | - |
dc.subject.keywordPlus | VENTRICULAR DILATATION | - |
dc.subject.keywordPlus | CEREBRAL-ISCHEMIA | - |
dc.subject.keywordPlus | CONTROLLED-TRIAL | - |
dc.subject.keywordPlus | ADIPOSE-TISSUE | - |
dc.subject.keywordPlus | BONE-MARROW | - |
dc.subject.keywordPlus | RAT | - |
dc.subject.keywordAuthor | Intraventricular hemorrhage (IVH) | - |
dc.subject.keywordAuthor | Infant | - |
dc.subject.keywordAuthor | Newborn | - |
dc.subject.keywordAuthor | Mesenchymal stem cells (MSCs) | - |
dc.subject.keywordAuthor | Cell transplantation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.